Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217165 · ClinicalTrials.gov registry record · Phase 2
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study
A Phase 2 study, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00217165 is a Phase 2 study that has completed, run by Mclean Hospital. The registered enrollment target is 60 participants.
The verdict
NCT00217165, a Phase 2 study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.
Interventions
- DRUG taurine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217165
The ClinicalTrials.gov registry entry for NCT00217165 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which taurine is the first listed.
NCT00217165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217165 about?
NCT00217165 is a clinical study titled "Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study". The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.
What is the current status of trial NCT00217165?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2005-04. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00217165?
The interventions under investigation include: taurine (DRUG).
Who is sponsoring clinical trial NCT00217165?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.